KONDO Shingo

写真a

Affiliation

Faculty of Pharmacy, Department of Pharmacy Social Pharmacy (Shiba-Kyoritsu)

Position

Research Associate/Assistant Professor/Instructor

Contact Address

1-5-30 shibakoen, Minato-ku, Tokyo
Page Top ▲

Career 【 Display / hide 】

  • 2017.04
    -
    2019.03

    Medical Hospital, Tokyo Medical and Dental University, Department of Pharmacy, pharmacist

  • 2019.04
    -
    2023.03

    慶應義塾大学薬学部, 化学療法学講座, 助教

  • 2023.04
    -
    Present

    慶應義塾大学薬学部, Social Pharmacy, 助教

  • 2023.04
    -
    Present

    慶應義塾大学薬学部附属薬局, 非常勤薬剤師

Page Top ▲

Academic Background 【 Display / hide 】

  • 2013.04
    -
    2017.03

    Keio University

    Graduate School, Completed, Doctoral course

Page Top ▲

Academic Degrees 【 Display / hide 】

  • Doctor（Pharmacy）, Keio University, Coursework, 2017.03

Page Top ▲

Licenses and Qualifications 【 Display / hide 】

  • Pharmacist license, 2013.07

Page Top ▲
 

Papers 【 Display / hide 】

  • Identification of Issues Related to Enteral Nutrients Using a Database of Near-miss Events from Community Pharmacies.

    Kondo S, Maese M, Iwata H, Kobayashi N, Yamaura K

    The Keio journal of medicine  2025.03

    ISSN  0022-9717

  • 腎機能の低下者に対して注意が必要なOTC医薬品の解析

    近藤 慎吾, 前瀬 鞠, 古堅 彩子, 岩田 紘樹, 小林 典子, 山浦 克典

    薬局薬学 (Pharmacy Society of Japan)  advpub ( 0 )  2024.12

    Lead author, Accepted,  ISSN  18843077

    　View Summary

    <p>Obtaining laboratory data on renal function in community pharmacies is challenging, as pharmacists rarely perform pharmaceutical interventions based on the patient’s renal function during over-the-counter (OTC) medication sales. This study aimed to identify OTC medications requiring caution in patients with impaired renal function using the Pharmaceuticals and Medical Devices Agency (PMDA) database. Moreover, we compared renal function-related cautionary notes in the package inserts of prescription drugs having the same composition. The analysis focused on the package inserts of OTC medications sold exclusively by pharmacists. Among these, 64% (9/14 cases) of pharmaceuticals requiring guidance (<i>yo-shidou</i> medication) and 80% (107/134 cases) of Category 1 OTC medications had renal function-related warnings in the “precautions for use (what you should not do/who should seek consultation)” section. For OTC medications containing famotidine and nizatidine, the dosage and administration were set lower than those for prescription drugs. Although these drugs can be used for patients with impaired renal function on prescription, their use is restricted as OTC medications. We believe that enabling self-checks of renal function at community pharmacies could expand the range of indications for OTC medications and promote notified self-medication.</p>

  • Sex-related differences regarding headache triggered by low barometric pressure in Japan.

    Fujimoto T., Iwata H., Kobayashi N., Kondo S., Yamaura K.

    BMC research notes 17 ( 1 ) 203 2024.07

    　View Summary

    Purpose: The prevalence of migraine headache is higher in women. Low barometric pressure is a factor in headache triggering, but sex-related differences have not been identified. The purpose of this study was to examine sex-related differences in headache triggered by low barometric pressure. Methods: Study subjects aged 20–49 years were randomly selected from a research company’s (Macromill, Inc.) web panel. Those with chronic migraine or tension-type headache invited to complete a web-based self-administered questionnaire. Logistic regression analysis was performed with the objective variable as the Headache Impact Test-6 (HIT-6) high scores (56 or more) or headache triggered by low barometric pressure. Results: Participants were 332 women and 337 men in the headache population. HIT-6 high scores were associated with age at headache occurrence 20 years or younger (OR: odds ratio 1.85, 95% CI: confidence interval 1.15–2.99, p = 0.012) and headache triggered by low barometric pressure (OR 2.11, 95%CI 1.51–2.94, p < 0.001). Headache triggered by low barometric pressure was significantly associated with women (OR 2.92, 95%CI 2.12–4.02, p < 0.001). Conclusions: Headache triggered by low barometric pressure were related to sex-related differences. It was suggested that a sex-specific treatment approach for headache triggering is needed.

  • 学習成果基盤型の薬学教育モデル・コア・カリキュラムに基づく実務実習の先行導入から実装後の取り組み評価

    河添仁, 岩田紘樹, 石川春樹, 近藤慎吾, 地引綾, 横山雄太, 小林典子, 鈴木小夜, 山浦克典, 中村智徳

    医療薬学 (Japanese Society of Pharmaceutical Health Care and Sciences)  50 ( 9 ) 455 - 464 2024.06

    Research paper (scientific journal), Accepted,  ISSN  1346342X

    　View Summary

    <p>Pharmacy practice experiences (PPEs) based on a revised model core curriculum for pharmaceutical education that incorporates outcome-based education have been implemented in Japan. PPEs is a 22-week period in both a community pharmacy and hospital and is characterized by “participatory and experiential learning,” “performance evaluation,” and “continuous involvement in eight representative diseases.” This mini-review describes the evaluation from preintroduction to implementation of PPEs. During the performance evaluation, using a rubric—consisting of a four-point score—for assessing pharmaceutical students’ performance instead of a rating scale of specific behavioral objectives was feasible. Pharmacist mentors and pharmaceutical students could measure the latter’s performance level and growth in PPEs at a community pharmacy or hospital using a rubric assessment. During the continuous involvement of eight representative diseases, sharing information tools between community pharmacies and hospitals substantially increased the implementation rate related to these eight diseases. Furthermore, experiences of eight representative diseases were considerably associated with the growth of pharmaceutical students’ performance. Results indicate that PPEs with which pharmaceutical students experience a wide range of involvement with eight representative diseases may effectively enhance their competencies.</p>

  • Lack of information on gender differences in the package inserts of prescription drugs in Japan

    Narumi Maida, Shingo Kondo, Masanori Ogawa, Naoko Hayashi, Hiroki Iwata, Noriko Kobayashi, Katsunori Yamaura

    Drug Discov Ther. (International Research and Cooperation Association for Bio & Socio-Sciences Advancement)  17 ( 6 ) 396 - 403 2023.12

    Research paper (scientific journal), Corresponding author, Accepted,  ISSN  1881-7831

    　View Summary

    <p>The package inserts of prescription drugs provide essential information for the proper administration of pharmacotherapy. The incidence of adverse reactions for several drugs is known to be higher in women than in men. However, no studies have examined whether information on gender differences is included in Japanese package inserts. Therefore, this study investigated information on gender differences in the package inserts of Japanese prescription drugs, using the drug information database JAMES provided by the Medical Information System Development Center and the Japan Pharmaceutical Information Center. Non-proprietary names of prescription drugs were yielded 1,679 in Japan. Of the 1,679 ingredients in package inserts of prescription drugs, 76 (4.5%) included information on gender differences. The number of inserts that contained information on gender differences in the "DOSAGE AND ADMINISTRATION," "ADVERSE REACTIONS," and "PHARMACOKINETICS" sections was 3, 16, and 62, respectively. Furthermore, in the "ADVERSE REACTIONS" section, 15 of the 16 inserts mentioned a higher frequency of adverse reactions in women compared with men. Importantly, most of the inserts with information on gender differences in the "PHARMACOKINETICS" section mentioned a higher area under the curve for women than for men. Most of the package inserts of prescription drugs with information on gender differences provide useful information aimed at preventing risks in women. However, there is an extreme lack of information on gender differences in the package inserts of prescription drugs in Japan, and we consider enhancing information on gender difference as an urgent issue. </p>

display all >>

Page Top ▲

Papers, etc., Registered in KOARA 【 Display / hide 】

Page Top ▲

Reviews, Commentaries, etc. 【 Display / hide 】

  • 薬局薬剤師による大腸がん検診受診勧奨の実態及び取り組みの意欲

    廣瀬 希海, 岩田 紘樹, 小林 典子, 近藤 慎吾, 中村 友紀, 山浦 克典

    日本臨床腫瘍薬学会雑誌 ((一社)日本臨床腫瘍薬学会)  36   392 - 392 2024.05

  • SYDE1はSW620細胞のP-gp発現を上昇させる(SYDE1 upregulates P-glycoprotein in human colorectal cancer SW620 cells)

    武田 卓, 近藤 慎吾, 片山 和浩, 加藤 優, 杉本 芳一

    日本癌学会総会記事 ((一社)日本癌学会)  81回   P - 1347 2022.09

    ISSN  0546-0476

  • ヒスチジン異化はメトトレキサート感受性の主要な決定因子である

    近藤 慎吾

    ファルマシア (公益社団法人日本薬学会)  55 ( 7 ) 702 2019.07

    Book review, literature introduction, etc., Single Work

Page Top ▲

Presentations 【 Display / hide 】

  • 新型コロナウイルス感染症第7波自宅療養者における一般用医薬品の適正使用の実態と課題

    藤本卓磨, 岩田紘樹, 小林典子, 近藤慎吾, 中村友紀, 山浦克典

    2023.11
    , 

    Oral presentation (general)

  • 頭痛およびヘルスリテラシーの評価スコアを用いた頭痛患者の特性分析

    近藤 慎吾, 藤本 卓磨, 岩田 紘樹, 小林 典子, 中村 友紀, 山浦 克典

    2023.09
    , 

    Oral presentation (general)

  • ヒト結腸がん細胞株の上皮間葉転換に伴うグルタミナーゼ阻害剤高感受性とATF4の発現低下

    加藤 優, 近藤 慎吾, 杉本 芳一

    第27回日本がん分子標的治療学会学術集会 (佐賀市文化会館) , 

    2023.06
    , 

    Oral presentation (general), 日本がん分子標的治療学会

  • BET阻害剤dBET6はSLUG導入EMT細胞のフェロトーシス感受性を増大させる

    加藤優, 深澤ゆかり, 近藤慎吾, 杉本芳一

    日本薬学会第142年会, 

    2023.03
    , 

    Oral presentation (general)

  • Histone deacetylaseの抑制によるABCG2の発現低下とside population細胞の減少

    春名俊志, 加藤優, 有村友希, 角石優花, 神山遥, 近藤慎吾, 杉本芳一

    日本薬学会第142年会, 

    2023.03
    , 

    Oral presentation (general)

display all >>

Page Top ▲

Research Projects of Competitive Funds, etc. 【 Display / hide 】

  • 口腔乾燥を誘導する薬剤の同定と薬剤師による臨床的介入の効果の検討

    2025.04
    -
    2028.03

    Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), No Setting

  • がん分子標的薬に対する細胞周期の変化と薬剤耐性の克服

    2021.04
    -
    2022.03

    学事振興資金（個人研究）, No Setting, Principal investigator

  • がん分子標的薬に対する耐性機構の解明

    2020.04
    -
    2021.03

    学事振興資金（個人研究）, No Setting, Principal investigator

Page Top ▲
 

Courses Taught 【 Display / hide 】

  • STUDY OF MAJOR FIELD: (SOCIAL PHARMACY)

    2025

  • SEMINAR: (SOCIAL PHARMACY)

    2025

  • RESEARCH FOR BACHELOR'S THESIS 1

    2025

  • PRIOR LEARNING FOR CLINICAL PRACTICE 5

    2025

  • PRE-CLINICAL TRAINING FOR HOSPITAL & COMMUNITY PHARMACY

    2025

display all >>

Page Top ▲

Courses Previously Taught 【 Display / hide 】

  • ETHICS FOR HEALTHCARE PROFESSIONALS

    Keio University

    2025.04
    -
    2026.03

  • PRACTICAL LEARNING ON SUPPORTING THE HEALTH PROMOTION OF COMMUNITY

    Keio University

    2025.04
    -
    2026.03

  • COMMUNITY PHARMACY

    Keio University

    2025.04
    -
    2026.03

  • RESEARCH FOR BACHELOR'S THESIS 1

    Keio University

    2025.04
    -
    2026.03

  • PHARMACEUTICAL-ENGLISH SEMINAR

    Keio University

    2024.04
    -
    2025.03

display all >>

Page Top ▲
 

Memberships in Academic Societies 【 Display / hide 】

  • 日本性差医学・医療学会, 

    2024.01
    -
    Present

  • 日本医療薬学会, 

    2023.08
    -
    Present

  • 日本がん分子標的治療学会, 

    2019.04
    -
    Present

  • 日本癌学会, 

    2012.04
    -
    Present

  • 日本薬学会, 

    2011.04
    -
    Present
Page Top ▲